• News
In the interview to The Wall Street Journal, Assistant Attorney General Makan Delrahim said that the Justice Department is preparing to research and investigate the generic drug industry and even go as far as filing cases for allegedly fixing prices. The department has been investigating possible criminal conduct by generic drug companies for years, but there has been little action so far.
In July 2019 the head of the Federal Antimonopoly Service Igor Artemiev at a meeting with Russian President Vladimir Putin said that in Russia, the problem of cartels is now most acute in the pharmaceutical industry. Three months later, we can see the progress in the battle with the cartels
The second day of the BRICS International Competition Conference has not only started with a varietal topic but was also concluded with another life and death importance level panel – pharmaceutical regulation. The issues that could be discussed within this area are vast; however, most of the representatives from BRICS competition authorities have focused on two common problems for all of the countries – generics and pricing.
Roundtable “Anticompetitive practices of the Big Pharma: response of the BRICS Competition Authorities” took place on September 25 within the framework of  the International Russia Competition Week
During Competition Week, on September 25, Alexey Ivanov acted as a moderator of the discussion held within the framework of the Working Group on the study of competition problems in pharmaceutical markets.
On March 24 at the World Trade Centre a joint meeting of the International Working Group on the research of competition issues in the pharmaceutical sector was held, with the Federal Antimonopoly Service of Russia, with a high-level panel discussion on: "the Experience of the BRICS countries in overcoming the HIV/AIDS epidemic: the availability of medicines".
On the 22-23rd June the BRICS Competition Law and Policy Forum took place at HSE St Petersburg. The international conference was organised jointly by the HSE-Skolkovo Institute for Law and Development, the Centre for Law, Economics and Society at UCL and the Russian Federal Antimonopoly Service (FAS). Heads of antitrust departments and experts from the BRICS and the EEC were joined by leading academics and experts on competition law from Europe and the US.